FDA Slaps Boxed Warning on Osteoporosis Drug
(MedPage Today) -- The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced Friday.
After a review...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Chronic Kidney Disease | Endocrinology | Orthopaedics | Osteoporosis | Urology & Nephrology | Warnings | Xgeva